A new trial for Follicular Lymphoma patients is trialing a combination of three drugs, in place of chemotherapy

A new trial for Follicular Lymphoma patients is trialing a combination of three drugs, in place of chemotherapy

An exciting new trial is open at Sir Charles Gairdner Hospital for patients with treatment-naïve Follicular Lymphoma: “LEVERAGE”

Follicular lymphoma is a common type of lymphoma, with thousands of West Australians each year living with the disease.

Associate Professor Chan Cheah, Consultant Haematologist in WA, has designed a new Clinical Trial which will see the evaluation of a novel combination of three drugs, in place of chemotherapy (the existing standard treatment).

This combination of treatments is designed to harness the immune system to target cancer cells, as well as priming them for self-destruction. The treatment is expected to be highly effective based and fewer side effects (such as hair loss, nerve damage and infections) compared with standard treatment, chemotherapy.

 

 

Visit our website for further information & contact details for the trial: www.bloodcancerwa.org.au

Share this post